Loading organizations...
Convergent Ventures is a venture capital firm investing in early-stage teams developing science-driven technologies within the health and sustainability sectors. The firm targets companies where the convergence of data with natural, physical, and human sciences drives significant financial returns and positive societal impacts, focusing on innovations that address critical challenges for human and planetary health.
Frank Levinson, Julia Davourie, Christina Jenkins, and Zach Jonasson founded the firm in 2023. Their collective insight centered on the profound impact science-driven technologies could have on human and environmental health. Leveraging their backgrounds in entrepreneurship, science, and medicine, they back and build companies poised for meaningful seed-stage change.
Convergent Ventures partners with founders and early-stage teams dedicated to improving global health and the planet. Its long-term vision is to foster iconic businesses that deliver substantial value and positively contribute to global well-being, advancing solutions for a healthier future through technological innovation.
Convergent Ventures has 2 tracked investments across 1 company. The latest tracked deal is $35.0M Series A in Profluent Bio in March 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 25, 2024 | Profluent Bio | $35.0M Series A | Nabeel Hyatt | Jeff Dean, AIR Street Capital, AIX Ventures, Insight Partners |
| Mar 1, 2024 | Profluent Bio | $35.0M Series U | Spark Capital | 8VC, AIR Street Capital, Insight Partners, Radical Ventures, Jack Boren, AIX Ventures, Jeff Dean |